Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy-Reference-Cited by-同舟云学术

Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy

Published:2024-02-20 Issue:1 Volume:46 Page:
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Zhang Qiong¹²³,Zhao Yan¹²³,Luo Yankun¹²³,Guo Songjia¹²³,Hou Haizhu¹²³,Han Xiaoli¹²³,Zhou Yun¹²³⁴

Affiliation:

1. Department of Nephrology, The Fifth Clinical Medical College of Shanxi Medical University, Fifth Hospital of Shanxi Medical University, Taiyuan, China

2. Shanxi Genetic Engineering Center for Experimental Animal Models, Taiyuan, China

3. Shanxi Provincial Key Laboratory of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, China

4. Department of Nephrology, Shanxi Province Integrated Traditional and Western Medicine Hospital, Taiyuan, China

Funder

Four Batches of Scientific Research Projects of Shanxi Provincial Health Commission

Central Guiding Local Science and Technology Development Fund Project

Naturel Science Foundation of Shanxi Province

Innovative Project of Postgraduate Education in Shanxi Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2024.2319326

Reference23 articles.

1. IgA Nephropathy: Core Curriculum 2021

2. IgA Nephropathy: An Interesting Autoimmune Kidney Disease

3. Long-Term Outcomes in IgA Nephropathy

4. Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management

5. microRNAs in glomerular diseases from pathophysiology to potential treatment target

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases;MedComm;2024-07-15

2. Biomarkers Related to Pathogenesis, Diagnosis and Treatment of IgA Nephropathy;Advances in Clinical Medicine;2024